Setup and Characterization of a High-Throughput Luminescence-Based Serum Bactericidal Assay (L-SBA) to Determine Functionality of Human Sera against

Shigella flexneri functional assay generalized modules for membrane antigens (GMMA) human luminescence serum bactericidal assay (SBA) vaccine

Journal

Biotech (Basel (Switzerland))
ISSN: 2673-6284
Titre abrégé: BioTech (Basel)
Pays: Switzerland
ID NLM: 9918383086206676

Informations de publication

Date de publication:
27 Jul 2022
Historique:
received: 14 06 2022
revised: 19 07 2022
accepted: 25 07 2022
entrez: 23 8 2022
pubmed: 24 8 2022
medline: 24 8 2022
Statut: epublish

Résumé

Shigellosis represents a major public health problem worldwide. The morbidity of the disease, especially in children in developing countries, together with the increase of antimicrobial resistance make a vaccine against

Identifiants

pubmed: 35997337
pii: biotech11030029
doi: 10.3390/biotech11030029
pmc: PMC9396978
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Front Immunol. 2021 May 04;12:671325
pubmed: 34017343
J Infect Public Health. 2018 Jul - Aug;11(4):451-454
pubmed: 29066021
Eur J Clin Microbiol Infect Dis. 1990 May;9(5):337-44
pubmed: 2373088
Vaccines (Basel). 2022 Feb 18;10(2):
pubmed: 35214786
Vaccine. 2006 Jun 12;24(24):5093-107
pubmed: 16838413
Front Immunol. 2021 Oct 15;12:725129
pubmed: 34721387
PLoS One. 2015 Aug 06;10(8):e0134478
pubmed: 26248044
Clin Vaccine Immunol. 2017 Feb 6;24(2):
pubmed: 27927680
Methods Mol Biol. 2022;2414:227-279
pubmed: 34784041
Appl Environ Microbiol. 2019 Mar 22;85(7):
pubmed: 30709819
High Throughput. 2020 Jun 08;9(2):
pubmed: 32521658
Lancet Infect Dis. 2018 Nov;18(11):1229-1240
pubmed: 30266330
mSphere. 2018 Jun 13;3(3):
pubmed: 29898979
Vaccine. 1990 Aug;8(4):353-7
pubmed: 2204243
Expert Rev Anti Infect Ther. 2015 Jan;13(1):69-80
pubmed: 25399653
Vaccine. 2017 Jan 11;35(3):419-426
pubmed: 27998639
Clin Infect Dis. 2014 Oct;59(7):933-41
pubmed: 24958238
Vaccine. 2016 Jun 3;34(26):2887-2894
pubmed: 26979135
Microorganisms. 2021 Nov 15;9(11):
pubmed: 34835485
Microorganisms. 2021 Jun 25;9(7):
pubmed: 34202102
J Immunol Methods. 2018 Oct;461:117-121
pubmed: 29969587
EClinicalMedicine. 2021 Aug 13;39:101076
pubmed: 34430837
J Infect Dis. 1991 Sep;164(3):533-7
pubmed: 1869840
J Health Popul Nutr. 2011 Oct;29(5):429-37
pubmed: 22106748
Lancet Glob Health. 2019 May;7(5):e568-e584
pubmed: 31000128
Clin Vaccine Immunol. 2010 Jul;17(7):1055-65
pubmed: 20463105
Anal Biochem. 2013 Mar 1;434(1):136-45
pubmed: 23142430
Clin Vaccine Immunol. 2011 Aug;18(8):1252-60
pubmed: 21715580
BioTech (Basel). 2021 Sep 18;10(3):
pubmed: 35822773
J Immunol. 1980 Dec;125(6):2778-84
pubmed: 7000906
J Infect Dis. 2020 Nov 9;222(11):1858-1868
pubmed: 31984416
EBioMedicine. 2021 Apr;66:103308
pubmed: 33813141
Am J Clin Nutr. 2005 Feb;81(2):495-502
pubmed: 15699240
PLoS One. 2017 Feb 13;12(2):e0172163
pubmed: 28192483
PLoS Negl Trop Dis. 2021 Oct 13;15(10):e0009826
pubmed: 34644291
Hum Vaccin Immunother. 2019;15(6):1401-1408
pubmed: 31070988

Auteurs

Francesca Mancini (F)

GSK Vaccines Institute for Global Health s.r.l (GVGH), via Fiorentina 1, 53100 Siena, Italy.

Francesca Micoli (F)

GSK Vaccines Institute for Global Health s.r.l (GVGH), via Fiorentina 1, 53100 Siena, Italy.

Omar Rossi (O)

GSK Vaccines Institute for Global Health s.r.l (GVGH), via Fiorentina 1, 53100 Siena, Italy.

Classifications MeSH